Dashboard
Manage Tickers

MCRBSeres Therapeutics, Inc.

Nasdaq serestherapeutics.com


$ 0.70 $ 0.00 (-0.3 %)    

Friday, 14-Jun-2024 15:54:21 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.7083
$ 0.73
$ 0.00 x 0
$ 0.00 x 0
$ 0.69 - $ 0.73
$ 0.54 - $ 6.10
2,104,398
na
103.48M
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-02-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-06-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-14-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/10/2024 16:31:08

why-gamestop-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-fridays-mid-day-session
Why GameStop Shares Are Trading Lower By O...
06/07/2024 17:07:30

oppenheimer-downgrades-seres-therapeutics-to-perform
Oppenheimer Downgrades Seres Therapeutics ...
06/07/2024 16:43:13

Oppenheimer analyst Jeff Jones downgrades Seres Therapeutics (NASDAQ:MCRB) from Outperform to Perform.

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/07/2024 16:31:05

canaccord-genuity-maintains-buy-on-seres-therapeutics-lowers-price-target-to-10
Canaccord Genuity Maintains Buy on Seres T...
06/07/2024 12:49:47

Canaccord Genuity analyst John Newman maintains Seres Therapeutics (NASDAQ:MCRB) with a Buy and lowers the price target from...

seres-therapeutics-shares-are-lower-higher-after-the-company-entered-a-memorandum-of-understanding-with-nestl-health-science-for-the-sale-of-its-vowst-assets-the-stock-initially-traded-higher-but-it-has-since-reversed
Seres Therapeutics shares are lower higher...
06/06/2024 16:52:22

seres-therapeutics-shares-are-trading-higher-after-the-company-entered-a-memorandum-of-understanding-with-nestl-health-science-for-the-sale-of-its-vowst-assets
Seres Therapeutics shares are trading high...
06/06/2024 10:33:54

seres-therapeutics-entered-into-a-non-binding-memorandum-of-understanding-with-nestl-health-science-for-the-sale-of-seres-vowst-assets-under-the-terms-of-the-pending-agreement-seres-is-due-to-receive-capital-infusions-including-an-upfront-payment
Seres Therapeutics Entered Into A Non-bind...
06/06/2024 10:33:10

Seres anticipates capital infusions, including an upfront payment, enabling the Company to fully retire its debt and extend i...

oppenheimer-maintains-outperform-on-seres-therapeutics-lowers-price-target-to-4
Oppenheimer Maintains Outperform on Seres ...
05/09/2024 16:50:17

Oppenheimer analyst Jeff Jones maintains Seres Therapeutics (NASDAQ:MCRB) with a Outperform and lowers the price target from...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 16:31:09

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 16:31:09

nasdaq-down-over-50-points-uber-posts-q1-loss
Nasdaq Down Over 50 Points; Uber Posts Q1 ...
05/08/2024 14:02:37

seres-therapeutics-q1-cash-and-cash-equivalents-of-1112m-is-expected-to-provide-cash-runway-into-q4-of-2024
Seres Therapeutics' Q1 Cash And Cash Equiv...
05/08/2024 11:07:10

seres-therapeutics-q1-2024-gaap-eps-027-beats-034-estimate
Seres Therapeutics Q1 2024 GAAP EPS $(0.27...
05/08/2024 11:05:53

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(...

seres-therapeutics-concludes-enrollment-in-cohort-2-of-phase-1b-trial-of-ser-155-in-allogeneic-hematopoietic-stem-cell-transplant-patients-clinical-data-readout-expected-end-of-q3-2024
Seres Therapeutics Concludes Enrollment In...
04/09/2024 11:11:45

seres-therapeutics-announced-that-on-march-25-2024-the-compensation-and-talent-committee-of-seres-board-of-directors-granted-inducement-equity-grants-of-700000-shares-to-marella-thorell-new-executive-vice-president-and-cfo
Seres Therapeutics Announced That On March...
03/28/2024 11:26:45

oppenheimer-maintains-outperform-on-seres-therapeutics-lowers-price-target-to-5
Oppenheimer Maintains Outperform on Seres ...
03/06/2024 13:59:45

Oppenheimer analyst Jeff Jones maintains Seres Therapeutics (NASDAQ:MCRB) with a Outperform and lowers the price target from...

emerson-electric-to-rally-more-than-19-here-are-10-top-analyst-forecasts-for-wednesday
Emerson Electric To Rally More Than 19%? H...
03/06/2024 13:00:40

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

chardan-capital-maintains-buy-on-seres-therapeutics-lowers-price-target-to-8
Chardan Capital Maintains Buy on Seres The...
03/06/2024 12:38:27

Chardan Capital analyst Keay Nakae maintains Seres Therapeutics (NASDAQ:MCRB) with a Buy and lowers the price target from $1...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)